federal_register: 2016-23523

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2016-23523 Biosimilar User Fee Act; Public Meeting; Correction Notice The Food and Drug Administration is correcting a notice entitled "Biosimilar User Fee Act; Public Meeting" that appeared in the Federal Register of September 19, 2016 (81 FR 64171). The document announced a public meeting to discuss proposed recommendations for the reauthorization of the Biosimilar User Fee Act (BsUFA) for fiscal years (FYs) 2018 through 2022. The document was published with the incorrect date of the closure of the docket and incorrect transcript information. This document corrects those errors. 2016-09-29 2016 9 https://www.federalregister.gov/documents/2016/09/29/2016-23523/biosimilar-user-fee-act-public-meeting-correction https://www.govinfo.gov/content/pkg/FR-2016-09-29/pdf/2016-23523.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration is correcting a notice entitled "Biosimilar User Fee Act; Public Meeting" that appeared in the Federal Register of September 19, 2016 (81 FR 64171). The document announced a public meeting to discuss proposed...  

Links from other tables